TNFα decreased Best-3 expression in endothelium. by Wei Song (30780)

“…(<b>C, D</b>) HUVECs were stimulated with TNFα (10 ng/ml) for different times as indicated. Quantitative PCR (C) and western blot (D) results show a time-dependent decrease of Best-3 expression. …”

FHL2 silencing decreases osteosarcoma cell growth. by Julia Brun (286504)

Vectorized siRNA TMPRSS2-ERG IV-SQ impaired tumour growth and restored differentiation <i>in vivo</i>. by Giorgia Urbinati (554921)

“…<p><b>a.</b> SCID mice (n = 5/group) bearing VCaP tumour xenografts were injected intravenously either with NaCl 0.9%, non-vectorized siRNA TMPRSS2-ERG IV, NPs siRNA control-SQ or NPs siRNA TMPRSS2-ERG IV-SQ twice per week during 6 weeks (1.8 mg/kg/mouse cumulative dose). …”

Iota toxin increases type E adherence while decreases type A adherence. by Leandro M. Redondo (708975)

IL-15 decreases angiogenesis <i>in vivo</i>. by Krizia Rohena-Rivera (3906838)

NDRG2 is decreased during LX-2 activation. by Jiandong Yang (196004)

APC decreases epithelial cytotoxicity induced by histones but not by NET. by Mona Saffarzadeh (180792)

Nur77 knockdown decreases cell viability and proliferation. by Alexa Tenga (2161780)

“…<p>(A) Daoy cells were transfected with 20 nM siNur77 or non-targeting control (NT), and cell viability was measured via the CellTiter-Glo assay every day for 3 days. …”

Human preterm infants diagnosed with IUGR have decreased Paneth cell counts compared to preterm non-IUGR control infants. by Camille M. Fung (844334)

“…Infants with a diagnosis of IUGR (n = 9) were compared to age-matched non-IUGR infants (n = 4). (A) IUGR infants had similar numbers of goblet cells per 100 epithelial cells compared to non-IUGR infants (p = 0.5). …”

Telomerase inhibition decreases the proliferation and tube formation of HUVECs. by Nadine Mahfouz (4097566)

Decreased HIF levels associated with hyperoxic cell state. by Julie M. Koeman (108185)

“…<p>(A) Normalized densitometry of HIF-1α protein levels (•),HIF-1β protein levels (▴), and HIF-1 DNA-binding activity (⧫) as presented in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1000176#pgen-1000176-g005" target="_blank">Figure 5B</a> of the Jiang et al. article. …”

<i>csrnp1a</i> knockdown decreases the number of blood cells in circulation. by Jaime Espina (106906)

“…(H) Chart summarizing the morpholino dose-phenotype quantifications of 26 hpf control embryos (n = 71) and injected with 2,5 ng (n = 69), 5 ng (n = 85) or 10 ng (n = 87) of Mocsrnp1a spt morpholino. …”

Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

“…The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”

The negative ecological impacts of a globally introduced species decrease with time since introduction by Libor Zavorka (828469)

Growth on stiff substrate results in mild lifespan extension but a decrease in organismal health. by Maria Oorloff (19658113)

NS4B decreases TRIF protein level. by Yisha Liang (5244368)

Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability. by Giorgia Urbinati (554921)

“…<p>VCaP cells were transfected for 72h from 2.5 nM to 50 nM with siRNA TMPRSS2-ERG III, siRNA TMPRSS2-ERG IV or siRNA Control. …”

Deterioration of the anammox process at decreasing temperatures and long SRTs by Maaike Hoekstra (3915545)

RNA interference-mediated decrease in Ixofin3D results in decreased <i>B. burgdorferi</i> burden in the salivary glands and in murine skin. by Sukanya Narasimhan (73432)

Mean (range) Ag content (ng Ag/cm²) of periphyton collected from all three lakes. by Beth C. Norman (754890)